GlycoMimetics, Inc. (GLYC) has 20 known insider and institutional holders on record. The largest holder is Siren, L.L.C. with 8,589,064 shares. Other notable holders include Invus Public Equities, L.P. and SANDELL SCOTT D.
GLYC Insider Ownership
Top Holder
Siren, L.L.C.
8,589,064 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Siren, L.l.c. |
10 Percent Owner |
8,589,064 |
2024-07-29 |
|
| 2 |
Invus Public Equities, L.p. |
10 Percent Owner |
6,578,438 |
2024-08-09 |
|
| 3 |
Sandell Scott D |
Director |
3,588,288 |
2023-01-27 |
|
| 4 |
Semerjian Harout |
Chief Executive Officer |
695,000 |
2024-01-17 |
|
| 5 |
Bvf Partners L P/il |
10 Percent Owner |
630,453 |
2020-11-06 |
|
| 6 |
Rock Edwin |
Chief Medical Officer |
565,403 |
2024-06-24 |
|
| 7 |
Magnani John L. |
SVP of Research, CSO |
366,078 |
2022-11-14 |
|
| 8 |
Rath Chinmaya |
SVP and Chief Business Officer |
250,000 |
2024-01-17 |
|
| 9 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
250,000 |
2024-01-17 |
|
| 10 |
Hahn Brian M. |
SVP Finance, CFO |
70,643 |
2024-06-20 |
|
| 11 |
Thackray Helen M. |
SVP Clinical Development, CMO |
69,000 |
2021-01-22 |
|
| 12 |
Junius Daniel M |
Director |
40,000 |
2024-05-01 |
|
| 13 |
Koenig Scott |
Director |
40,000 |
2024-05-01 |
|
| 14 |
Andrews Patricia S |
Director |
40,000 |
2024-05-01 |
|
| 15 |
Pearson Timothy R |
Director |
40,000 |
2024-05-01 |
|
| 16 |
Goldberg Mark Alan |
Director |
40,000 |
2024-05-01 |
|
| 17 |
King Rachel K. |
Director |
40,000 |
2024-05-01 |
|
| 18 |
Jackson Scott Thomas |
Director |
40,000 |
2024-05-01 |
|
| 19 |
Girard Armand |
SVP, Chief Business Officer |
29,161 |
2022-11-14 |
|
| 20 |
Gust William M. |
Director |
15,401 |
2014-01-13 |
|
No ownership data available for GLYC.
